S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

ONCY Oncolytics Biotech Inc

0.6842

0.00 (0.00%)

Pre Market

Last Updated: 20:39:33

Delayed by 15 minutes

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Oncolytics Biotech (NASDAQ:ONCY)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Oncolytics Biotech Charts.

Oncolytics Biotech (NASDAQ:ONCY)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Oncolytics Biotech Charts.

Oncolytics Biotech Inc News

Oncology Breakthroughs: How Cancer Research Is Advancing in 2025
Friday 28 February 2025 (19 hours ago) • PR Newswire (US)

Oncology Breakthroughs: How Cancer Research Is Advancing in 2025
Friday 28 February 2025 (19 hours ago) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 26 February 2025 (3 days ago) • Edgar (US Regulatory)

Investors Eye Biotech Sector as Cancer Therapy Market Surges
Thursday 20 February 2025 (1 week ago) • PR Newswire (US)

Investors Eye Biotech Sector as Cancer Therapy Market Surges
Thursday 20 February 2025 (1 week ago) • PR Newswire (Canada)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 20 February 2025 (1 week ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 19 February 2025 (1 week ago) • Edgar (US Regulatory)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Saturday 15 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Saturday 15 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 11 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Oncology's Best Minds Set to Meet at Upcoming 2025 ASCO Gastrointestinal Cancers Symposium
Thursday 23 January 2025 (1 month ago) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 22 January 2025 (1 month ago) • Edgar (US Regulatory)

More Oncolytics Biotech Inc News Articles

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions